Clinical trial

Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional…

NCT00474279 · University of Virginia, Other · Completed

Key facts

NCT number NCT00474279
Title Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults
Official title Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults
Acronym MOT089
Lead sponsor University of Virginia, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Aging
Intervention type Drug
Interventions Orally active growth hormone secretagogue (MK-677)
Enrollment 72
Start date Jul 1, 1998
Completion Jun 1, 2004
First posted May 16, 2007
Last update posted May 16, 2007
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies